Finance

Lists
JANX:NASDAQ
Janux Therapeutics Inc
$11.37
-1.09%
(-0.12) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JANX...
Open
$11.50
High
$11.56
Low
$11.16
Mkt. cap
695.35M
Avg. vol.
992.86K
Volume
717.85K
52-wk high
$35.25
52-wk low
$11.16
EPS
-$1.59
Beta
2.44
Shares outstanding
61.18M
No. of employees
114
Open
$11.50
High
$11.56
Low
$11.16
Mkt. cap
695.35M
Avg. vol.
992.86K
Volume
717.85K
52-wk high
$35.25
52-wk low
$11.16
EPS
-$1.59
Beta
2.44
Shares outstanding
61.18M
No. of employees
114
News stories
From web sources and news partners
About Janux Therapeutics Inc
CEO-
Employees114
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 12 analysts giving stock ratings to JANX in the past 3 months
Buy
Buy
9
Hold
2
Sell
1
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for JANX in the last 3 months.
Highest
Current $11.37
$55.00 (+383.73%)
Average
$30.80 (+170.89%)
Lowest
$15.00 (+31.93%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$45.00
+295.8%
11/12/2026
Kalpit Patel
Wolfe Research
Hold
Downgraded
-
-
11/12/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$34.00
+199%
11/10/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
$26.00
+128.7%
11/10/2026
David Dai
UBS
Hold
Reiterated
$15.00
+31.9%
11/10/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
11/09/2026
Boris Peaker
JonesTrading
Buy
Maintained
$28.00
+146.3%
11/06/2026
Supawat Thongthip
Truist Financial
Buy
Maintained
$27.00
+137.5%
11/06/2026
Robert Driscoll
Wedbush
Buy
Reiterated
$40.00
+251.8%
11/06/2026
Bradley Canino
Guggenheim
Buy
Maintained
$55.00
+383.7%
11/05/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
$23.00
+102.3%
11/06/2026
Etzer Darout
Barclays
Sell
Maintained
$15.00
+31.9%
11/06/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
$60.00
+427.7%
08/07/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
$22.00
+93.5%
05/11/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/08/2026
Unknown Analyst
Wedbush
Buy
Reiterated
$36.00
+216.6%
05/08/2026
Soumit Roy
JonesTrading
Buy
Maintained
$50.00
+339.8%
04/06/2026
Karina Rabayeva
Truist Financial
Buy
Reiterated
$80.00
+603.6%
03/03/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
$100.00
+779.5%
02/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
3.73M
10.27M
9.29M
Cost of goods sold
31.55M
26.81M
30.99M
30.56M
Cost of revenue
31.55M
26.81M
30.99M
30.56M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.85M
11.13M
10.96M
9.98M
Operating expense
10.85M
11.13M
10.96M
9.98M
Total operating expenses
42.40M
37.95M
41.96M
40.55M
Operating income
-42.40M
-34.21M
-31.69M
-31.26M
Other non operating income
-
-
-
-
EBT including unusual items
-31.95M
-24.36M
-21.97M
-21.57M
EBT excluding unusual items
-31.95M
-24.36M
-21.97M
-21.57M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-31.95M
-24.36M
-21.97M
-21.57M
Net profit margin
-
-652.59%
-214.01%
-232.21%
Earnings per share
-0.51
-0.39
-0.35
-0.34
Interest and investment income
10.46M
9.85M
9.72M
9.69M
Interest expense
-
-
-
-
Net interest expenses
10.46M
9.85M
9.72M
9.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
-41.93M
-33.74M
-31.23M
-30.80M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps